IIT-Kanpur and NAP Limited Signs MOU for Research in Bioengineering and Hemp Pharmaceuticals

  • HOME
  • /
  • News
  • /
  • IIT-Kanpur and NAP Limited Signs MOU for Research in Bioengineering and Hemp Pharmaceuticals

IIT-Kanpur and NAP Limited Signs MOU for Research in Bioengineering and Hemp Pharmaceuticals
07-Sep-22 05:19:07

The Indian Institute of Technology-Kanpur has collaborated with Niche Agriculture & Pharmaceuticals Limited (NAPL) for research in the field of hemp cultivation and formulation of advanced medicines for treating chronic medical conditions.

India’s premier research institute IIT-Kanpur ink Memorandum Of Understanding with Niche Agriculture & Pharmaceuticals Limited, a company engaged in Agricultural activities and formulation of advanced medicines, to do research on cultivation of the ‘Cannabis’ and its usage in pharma and bioengineering. This collaboration between the two parties will focus on research, development, and consultancy studies in the fields of mutual interest.

The MoU was signed by Prof. Abhay Karandikar, Director, IIT Kanpur, and Harisharan Devgan, Chairman of Niche Group of Companies, in the presence of esteemed Senior Professors, researchers, and other faculty members.

By partnering together, the Indian Institute of Technology Kanpur and Niche Agriculture & Pharmaceuticals Limited are setting the groundwork for reorganising the indigenous cannabis plant and creating new hemp cultivars that adhere to international regulations. The development of new hemp-based treatments will help doctors address the rising rates of cancer, epilepsy, migraine, chronic pain, arthritis, and insomnia in India.

Abhay Karandikar, Director of IIT-Kanpur, said, “He is looking forward to this collaboration. Furthermore, he added that it will lay the foundation for better research and development in the biotech industry. Cannabis has been widely accepted in Indian culture through the ages, yet we have limited knowledge about this holy plant. “Cannabis is known for its medical benefits. Still, it is facing massive criticism due to its intoxicating effects.”

Commenting on the MoU, Niche Agriculture & Pharmaceuticals Limited Chairman, Mr. Harisharan Devgan, quoted, “This cooperation with IIT-Kanpur will strengthen our goal to toil towards the exploration of cannabis plants for the progression of the healthcare sector. This collaboration will not only grant access to a whole new range of medicinal formulations, but it will also offer people affordable medical treatment for chronic health problems. We are focusing on improving cooperation in the field of Hemp Cultivation and Bioengineering and implementing technologies like tissue culture with IIT-Kanpur for research and development, and exchanging academic materials and publications for the formulation of hemp-based and other medicines for chronic diseases.

Niche Agriculture & Pharmaceuticals Limited is inclined to research new medicinal formulations to help the Indian healthcare sector keep evolving. The MoU also focuses on the exchange of academic materials and publications and extends to formulating hemp-based and other medicines for chronic diseases.

SOURCE: India Education Diary